Analysen von Emily Field
| 12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
| 11.05.22 | Roche Overweight | Barclays Capital | |
| 11.05.22 | Bayer Overweight | Barclays Capital | |
| 10.05.22 | Bayer Overweight | Barclays Capital | |
| 04.05.22 | Merck Overweight | Barclays Capital | |
| 29.04.22 | GSK Equal Weight | Barclays Capital | |
| 26.04.22 | Roche Overweight | Barclays Capital | |
| 04.04.22 | Bayer Overweight | Barclays Capital | |
|
Werbung
|
|||
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 09.03.22 | Sanofi Equal Weight | Barclays Capital | |
| 04.03.22 | Merck Overweight | Barclays Capital | |
| 21.02.22 | Bayer Equal Weight | Barclays Capital | |
| 17.02.22 | Bayer Equal Weight | Barclays Capital | |
| 15.02.22 | Novo Nordisk Overweight | Barclays Capital | |
| 15.02.22 | AstraZeneca Overweight | Barclays Capital | |
| 08.02.22 | Sanofi Equal Weight | Barclays Capital | |
| 07.02.22 | Roche Overweight | Barclays Capital | |
| 04.02.22 | Roche Overweight | Barclays Capital | |
| 02.02.22 | Novartis Underweight | Barclays Capital | |
| 31.01.22 | Sanofi Equal Weight | Barclays Capital | |
| 31.01.22 | Novartis Underweight | Barclays Capital | |
| 31.01.22 | Roche Overweight | Barclays Capital | |
| 31.01.22 | AstraZeneca Overweight | Barclays Capital | |
| 31.01.22 | Novo Nordisk Overweight | Barclays Capital | |
| 31.01.22 | MorphoSys Equal Weight | Barclays Capital | |
| 28.01.22 | GSK Equal Weight | Barclays Capital | |
| 17.01.22 | GSK Equal Weight | Barclays Capital | |
| 21.12.21 | Novo Nordisk Overweight | Barclays Capital | |
| 02.12.21 | Sanofi Equal Weight | Barclays Capital | |
| 22.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 16.11.21 | Bayer Equal Weight | Barclays Capital | |
| 10.11.21 | Bayer Equal Weight | Barclays Capital | |
| 10.11.21 | AstraZeneca Overweight | Barclays Capital | |
| 05.11.21 | GSK Equal Weight | Barclays Capital | |
| 04.11.21 | Novo Nordisk Overweight | Barclays Capital | |
| 28.10.21 | GSK Underweight | Barclays Capital | |
| 27.10.21 | Novartis Underweight | Barclays Capital | |
| 20.10.21 | Bayer Equal Weight | Barclays Capital | |
| 20.10.21 | Roche Overweight | Barclays Capital | |
| 18.10.21 | Novo Nordisk Overweight | Barclays Capital | |
| 24.09.21 | AstraZeneca Overweight | Barclays Capital | |
| 08.09.21 | Sanofi Equal Weight | Barclays Capital | |
| 06.08.21 | Bayer Equal Weight | Barclays Capital | |
| 05.08.21 | Bayer Equal Weight | Barclays Capital | |
| 05.08.21 | Novo Nordisk Overweight | Barclays Capital | |
| 29.07.21 | GSK Underweight | Barclays Capital | |
| 19.07.21 | MorphoSys Equal Weight | Barclays Capital | |
| 19.07.21 | Merck Equal Weight | Barclays Capital | |
| 19.07.21 | Bayer Equal Weight | Barclays Capital | |
| 19.07.21 | Novo Nordisk Overweight | Barclays Capital | |